Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis
Amit G. Singal, Nabihah Tayob, Anand S. Mehta, et al.
Hepatology (2021) Vol. 75, Iss. 3, pp. 541-549
Open Access | Times Cited: 122

Showing 1-25 of 122 citing articles:

AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
Amit G. Singal, Josep M. Llovet, Mark Yarchoan, et al.
Hepatology (2023) Vol. 78, Iss. 6, pp. 1922-1965
Open Access | Times Cited: 713
Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma
Philip J. Johnson, Qing Zhou, Doan Y Dao, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 10, pp. 670-681
Closed Access | Times Cited: 208
The Performance of AFP, AFP-3, DCP as Biomarkers for Detection of Hepatocellular Carcinoma (HCC): A Phase 3 Biomarker Study in the United States
Nabihah Tayob, Fasiha Kanwal, Abeer Alsarraj, et al.
Clinical Gastroenterology and Hepatology (2022) Vol. 21, Iss. 2, pp. 415-423.e4
Open Access | Times Cited: 141
Blood-based biomarkers for hepatocellular carcinoma screening: Approaching the end of the ultrasound era?
Neehar D. Parikh, Nabihah Tayob, Amit G. Singal
Journal of Hepatology (2022) Vol. 78, Iss. 1, pp. 207-216
Open Access | Times Cited: 103
Hepatocellular carcinoma surveillance — utilization, barriers and the impact of changing aetiology
Daniel Q. Huang, Amit G. Singal, Fasiha Kanwal, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 12, pp. 797-809
Closed Access | Times Cited: 86
Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region
Do Young Kim, Bao Nguyen Toan, Chee‐Kiat Tan, et al.
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 2, pp. 277-292
Open Access | Times Cited: 66
Battle of the biopsies: Role of tissue and liquid biopsy in hepatocellular carcinoma
Brandon M. Lehrich, Josephine Zhang, Satdarshan P. Monga, et al.
Journal of Hepatology (2023) Vol. 80, Iss. 3, pp. 515-530
Open Access | Times Cited: 47
Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma
Yau-Tuen Chan, Cheng Zhang, Junyu Wu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 38
Alpha-fetoprotein: Past, present, and future
Yee Hui Yeo, Yi‐Te Lee, Hsian‐Rong Tseng, et al.
Hepatology Communications (2024) Vol. 8, Iss. 5
Open Access | Times Cited: 22
Association between ultrasound quality and test performance for HCC surveillance in patients with cirrhosis: a retrospective cohort study
Nicolas Chong, Haley Schoenberger, Sruthi Yekkaluri, et al.
Alimentary Pharmacology & Therapeutics (2022) Vol. 55, Iss. 6, pp. 683-690
Closed Access | Times Cited: 67
Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease
Naoto Fujiwara, Naoto Kubota, Émilie Crouchet, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 650
Open Access | Times Cited: 67
Risk stratification and early detection biomarkers for precision HCC screening
Yi‐Te Lee, Naoto Fujiwara, Ju Dong Yang, et al.
Hepatology (2022), pp. n/a-n/a
Open Access | Times Cited: 60
HCC EV ECG score: An extracellular vesicle‐based protein assay for detection of early‐stage hepatocellular carcinoma
Na Sun, Ceng Zhang, Yi‐Te Lee, et al.
Hepatology (2022) Vol. 77, Iss. 3, pp. 774-788
Open Access | Times Cited: 58
Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection
Chih‐Lin Lin, Jia‐Horng Kao
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 3, pp. 605-622
Open Access | Times Cited: 40
International Liver Cancer Association (ILCA) white paper on hepatocellular carcinoma risk stratification and surveillance
Amit G. Singal, Marco Sanduzzi‐Zamparelli, Pierre Nahon, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 1, pp. 226-239
Open Access | Times Cited: 40
Hepatocellular carcinoma surveillance may be associated with potential psychological harms in patients with cirrhosis
Manasa Narasimman, Rubén Hernáez, Vanessa Cerda, et al.
Hepatology (2023) Vol. 79, Iss. 1, pp. 107-117
Closed Access | Times Cited: 37
Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review
Endrit Shahini, Giuseppe Pasculli, Antonio Giovanni Solimando, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4286-4286
Open Access | Times Cited: 29
The Performance of GALAD Score for Diagnosing Hepatocellular Carcinoma in Patients with Chronic Liver Diseases: A Systematic Review and Meta-Analysis
Ming‐Cheng Guan, Shiyu Zhang, Qian Ding, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 3, pp. 949-949
Open Access | Times Cited: 28
Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: The Multicenter Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study
K. Rajender Reddy, Dale McLerran, Tracey L. Marsh, et al.
Gastroenterology (2023) Vol. 165, Iss. 4, pp. 1053-1063.e6
Open Access | Times Cited: 27
Individualized HCC surveillance using risk stratification scores in advanced fibrosis and cirrhotic HCV patients who achieved SVR: Prospective study
Gamal Shiha, Ayman Hassan, Nasser Mousa, et al.
Alimentary Pharmacology & Therapeutics (2024)
Closed Access | Times Cited: 9
Opportunities to address gaps in early detection and improve outcomes of liver cancer
Brian J. McMahon, Chari Cohen, Robert S. Brown, et al.
JNCI Cancer Spectrum (2023) Vol. 7, Iss. 3
Open Access | Times Cited: 21
Development and clinical validation of a novel algorithmic score (GAAD) for detecting HCC in prospective cohort studies
Teerha Piratvisuth, Jinlin Hou, Tawesak Tanwandee, et al.
Hepatology Communications (2023) Vol. 7, Iss. 11
Open Access | Times Cited: 18
Cost-effectiveness of a precision hepatocellular carcinoma surveillance strategy in patients with cirrhosis
Szu-Yu Zoe Kao, Kinpritma Sangha, Naoto Fujiwara, et al.
EClinicalMedicine (2024) Vol. 75, pp. 102755-102755
Open Access | Times Cited: 7
Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Soo Young Hwang, Pojsakorn Danpanichkul, Vatche G. Agopian, et al.
Clinical and Molecular Hepatology (2024)
Open Access | Times Cited: 7
Overdiagnosis of hepatocellular carcinoma: Prevented by guidelines?
Nicole E. Rich, Amit G. Singal
Hepatology (2021) Vol. 75, Iss. 3, pp. 740-753
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top